| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9aa4d7ac4628b72dd48dd67f6a436fc9 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C309-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C309-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2020-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a85426d5f6826dfc7f5446d8afd5097f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5949f117faf4683e7cb2d34385bd06c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd840c3dd3c0395d6ee0893c3dbe8e80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1893c22d11a5716487975e79672ed736 |
| publicationDate |
2022-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20220011705-A |
| titleOfInvention |
Crystalline form as c-MET/AXL inhibitor |
| abstract |
The present invention relates to a crystalline form or a salt form of a uracil compound as a c-MET/AXL inhibitor, and a method for preparing the same, and also discloses the use of the crystalline form and the salt form in the manufacture of a drug for treating a tumor. |
| priorityDate |
2019-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |